Yasuhiro Okamoto Selected Research

Drug Therapy (Chemotherapy)

1/2020	Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease.
1/2019	[Acute myeloid leukemia evolving from KIT D816-mutated systemic mastocytosis relapsing two months after completion of chemotherapy].
1/2019	Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
1/2018	Thiamylal Plus Pentazocine Shows Similar Efficacy as Ketamine Plus Midazolam for Painful Procedures in Children With Leukemia.
1/2018	Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia.
1/2017	Decrease of Cardiac Base Rotation in 2D Speckle Tracking Indicates Drug-induced Cardiomyopathy After Chemotherapy in Children With Cancer.
10/2016	Conservative treatment of massive hemothorax in a girl with neuroblastoma.
1/2014	Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
1/2012	Posterior fossa immature teratoma in an infant with trisomy 21: A case report and review of the literature.
1/2009	Critical illness polyneuropathy after Bacillus cereus sepsis in acute lymphoblastic leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Okamoto Research Topics

Disease

16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 07/2008
12	Neoplasms (Cancer) 07/2021 - 05/2003
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 01/2011
8	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 08/2009
8	Leukemia 01/2021 - 12/2013
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 08/2002
4	Infections 01/2021 - 09/2003
4	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2019 - 04/2011
4	Fever (Fevers) 01/2019 - 07/2010
3	Neuroblastoma 07/2021 - 10/2016
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 07/2014
3	Sepsis (Septicemia) 08/2014 - 09/2003
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2017
2	Hemorrhage 01/2021 - 01/2016
2	Weight Gain 01/2019 - 01/2018
2	Body Weight (Weight, Body) 01/2018 - 06/2009
2	Osteoporosis 11/2017 - 06/2011
2	Cardiotoxicity 08/2017 - 01/2015
2	Disease Progression 04/2017 - 05/2012
2	Congenital Bone Marrow Failure Syndromes 03/2015 - 06/2014
2	Pain (Aches) 11/2014 - 08/2009
2	Pathologic Complete Response 07/2014 - 09/2009
2	Myeloid Leukemia (Leukemia, Myelocytic) 03/2014 - 01/2012
1	Acidosis 01/2022
1	Residual Neoplasm 01/2022
1	Diarrhea 07/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Thrombocytopenia 1 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Bacteremia 01/2020
1	Cytopenia 01/2020
1	Bone Marrow Failure Disorders 01/2020
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2020
1	Pneumococcal Infections 01/2020
1	Pancytopenia 01/2019
1	Systemic Mastocytosis 01/2019
1	Urinary Retention 12/2018
1	Hemangioma (Angioma) 12/2018
1	Obesity 01/2018
1	Overweight 01/2018
1	Cerebral Palsy (Spastic Diplegia) 11/2017
1	Lymphoma (Lymphomas) 01/2017

Drug/Important Bio-Agent (IBA)

4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 09/2003
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 08/2009
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 08/2002
3	fludarabineIBA 01/2020 - 11/2006
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 08/2002
3	Benzene (Benzole)IBA 03/2014 - 01/2011
2	nelarabine (506U78)FDA Link 01/2022 - 01/2017
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 05/2015
2	SteroidsIBA 01/2018 - 01/2014
2	Pentazocine (Talwin)FDA LinkGeneric 01/2018 - 08/2009
2	Acrolein (Aqualin)IBA 08/2017 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2017 - 11/2016
2	Oxygen (Dioxygen)IBA 10/2016 - 07/2010
2	Busulfan (Busulfex)FDA Link 05/2015 - 12/2013
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	gilteritinibIBA 11/2021
1	nuclear pore complex protein 98IBA 11/2021
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2021
1	ElectrolytesIBA 07/2021
1	GlobulinsIBA 01/2021
1	eltrombopag FDA Link 01/2021
1	VaccinesIBA 01/2020
1	Brentuximab VedotinIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Prednisolone (Predate)FDA LinkGeneric 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Propranolol (Inderal)FDA LinkGeneric 12/2018
1	Thiamylal (Surital)FDA Link 01/2018
1	Ketamine FDA LinkGeneric 01/2018
1	Midazolam (Versed)FDA LinkGeneric 01/2018
1	Vitamin K FDA Link 11/2017
1	OsteocalcinIBA 11/2017
1	Vitamin K 2 (Vitamin K2)IBA 11/2017
1	carboxyethylphosphoramide mustardIBA 08/2017
1	Aldehyde DehydrogenaseIBA 08/2017
1	3-Iodobenzylguanidine (Iobenguane)IBA 04/2017

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2020 - 05/2003
15	Therapeutics 01/2022 - 09/2003
7	Transplantation 01/2020 - 12/2003
6	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2013
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020 - 08/2009
4	Induction Chemotherapy 01/2020 - 04/2011
4	Aftercare (After-Treatment) 05/2019 - 09/2016
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2022 - 04/2017
3	Stem Cell Transplantation 08/2019 - 08/2013
2	Cell Transplantation 01/2021 - 05/2015
2	Immunotherapy 02/2019 - 11/2006
2	Blood Transfusion (Blood Transfusions) 10/2016 - 08/2014
1	Cystostomy (Suprapubic Cystostomy) 01/2022
1	Urinary Catheters 01/2022
1	Oral Administration 12/2018